{"id":309855,"date":"2019-12-13T21:30:01","date_gmt":"2019-12-14T05:30:01","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/healthcare-roundup-eagle-pharma-on-go-to-launch-alimta-alternative-fda-clears-boston-scientific-single-use-duodenoscope\/"},"modified":"2019-12-13T21:30:44","modified_gmt":"2019-12-14T05:30:44","slug":"%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8-eagle-pharma-%e5%8d%b3%e5%b0%87%e6%8e%a8%e5%87%ba-alimta-%e6%9b%bf%e4%bb%a3%e5%93%81-fda%e6%89%b9%e5%87%86-boston-scientific-%e4%b8%80%e6%ac%a1","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/12\/%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8-eagle-pharma-%e5%8d%b3%e5%b0%87%e6%8e%a8%e5%87%ba-alimta-%e6%9b%bf%e4%bb%a3%e5%93%81-fda%e6%89%b9%e5%87%86-boston-scientific-%e4%b8%80%e6%ac%a1\/","title":{"rendered":"\u91ab\u7642\u4fdd\u5065\u7cbe\u9078\u2014\u2014Eagle Pharma\u5373\u5c07\u63a8\u51faAlimta\u66ff\u4ee3\u54c1\uff0cFDA\u6279\u51c6Boston Scientific\u4e00\u6b21\u6027\u5341\u4e8c\u6307\u8178\u93e1"},"content":{"rendered":"

Eagle Pharma\u5c07\u65bc2022\u5e74\u521d\u63a8\u51fa\u816b\u7624\u85e5\u611b\u752f\u9054\u66ff\u4ee3\u54c1<\/h2>\n

Eagle Pharmaceuticals\uff08EGRX + 2.5%\uff09<\/a>\u5df2\u89e3\u6c7a\u4e86\u79ae\u4f86\uff08LLY-0.3%\uff09\u8207\u5f8c\u8005\u7684\u5316\u5b78\u85e5\u7269\u611b\u752f\u9054\uff08Alimta\uff0c\u6ce8\u5c04\u7528\u57f9\u7f8e\u66f2\u585e\uff09\u6709\u95dc\u7684\u6240\u6709\u5c08\u5229\u554f\u984c\u3002<\/p>\n

\u6839\u64da\u548c\u89e3\u5354\u8b70\u7684\u689d\u6b3e\uff0cEagle\u6700\u521d\u5c07\u901a\u904e\u5176\u66ff\u4ee3\u7522\u54c1Pemfexy\u9032\u5165\u7f8e\u570b\u5e02\u5834\uff0c\u4e26\u65bc2022\u5e742\u67081\u65e5\u4e0a\u5e02\uff0c\u7136\u5f8c\u57282022\u5e744\u67081\u65e5\u5168\u9762\u6295\u5165\u5546\u696d\u904b\u71df\u3002<\/p>\n

Monopar Therapeutics\u7e2e\u5c0fIPO\u898f\u6a21<\/h2>\n

Monopar Therapeutics\uff08MNPR\uff09<\/a>\u5df2\u63d0\u4ea4\u521d\u6b65\u62db\u80a1\u8aaa\u660e\u66f8\uff0c\u4ee5\u6bcf\u80a18-10\u7f8e\u5143\u7684\u50f9\u683c\u767c\u884c\u7d04110\u842c\u80a1\u666e\u901a\u80a1\u3002<\/p>\n

9\u6708\uff0c\u8a72\u516c\u53f8\u7533\u8acb\u4ee5\u76f8\u540c\u7684\u50f9\u683c\u767c\u884c\u7d04440\u842c\u80a1\u80a1\u7968\u3002<\/p>\n

FDA\u6279\u51c6Boston Scientific\u4e00\u6b21\u6027\u5341\u4e8c\u6307\u8178\u93e1<\/h2>\n

FDA\u6388\u4e88\u6279\u51c6Boston Scientific\u4e00\u6b21\u6027\u5341\u4e8c\u6307\u8178\u93e1EXALT\uff0c\u7528\u65bc\u5167\u7aba\u93e1\u9006\u884c\u80f0\u81bd\u7ba1\u9020\u5f71\u8853\uff08\u65e8\u5728\u8a3a\u65b7\u809d\u81df\uff0c\u81bd\u56ca\uff0c\u81bd\u7ba1\u548c\u80f0\u817a\u4e2d\u7684\u554f\u984c\u3002<\/p>\n

\u8a72\u516c\u53f8\u8868\u793a\uff0c\u9019\u662f\u7f8e\u570b\u7b2c\u4e00\u53f0\u9019\u7a2e\u4e00\u6b21\u6027\u4f7f\u7528\u7684\u8a2d\u5099\uff08\u5176\u4ed6\u5341\u4e8c\u6307\u8178\u93e1\u662f\u53ef\u91cd\u8907\u4f7f\u7528\u7684\uff0c\u5982\u679c\u672a\u5fb9\u5e95\u6e05\u6f54\uff0c\u5247\u5b58\u5728\u611f\u67d3\u98a8\u96aa\uff09\u3002<\/p>\n

Tenet \u51fa\u552e\u91ab\u9662\u7b49\u8a2d\u65bd<\/h2>\n

Tenet Healthcare\uff08THC + 0.6%\uff09<\/a>\u540c\u610f\u4ee5\u672a\u516c\u958b\u7684\u50f9\u683c\u51fa\u552e\u5169\u5bb6\u91ab\u9662\u53ca\u5176\u76f8\u95dc\u7684\u91ab\u5e2b\u8a3a\u6240\u548c\u516d\u500b\u6025\u8a3a\u4e2d\u5fc3\u3002\u8a72\u4ea4\u6613\u61c9\u57282020\u5e74\u5b8c\u6210\u3002<\/p>\n

\u6b50\u6d32\u8aee\u8a62\u6279\u51c6\u64f4\u5927\u8f1d\u745eVyndaqel \u6cbb\u7642\u7bc4\u570d<\/h2>\n

\u6b50\u6d32\u85e5\u54c1\u7ba1\u7406\u5c40\u7684\u8aee\u8a62\u5c0f\u7d44CHMP\u901a\u904e\u4e86\u4e00\u9805\u7a4d\u6975\u7684\u610f\u898b\uff0c\u5efa\u8b70\u6279\u51c6\u8f1d\u745e\u516c\u53f8\uff08NYSE\uff1aPFE\uff09<\/a>\u7684Vyndaqel\uff08\u4ed6\u6cd5\u7c73\u5730\uff09\u7528\u65bc\u6bcf\u65e5\u4e00\u6b21\u6cbb\u7642\u60a3\u6709\u5fc3\u808c\u75c5\u7684\u6210\u4eba\u7684\u91ce\u751f\u578b\u6216\u907a\u50b3\u6027\u7532\u72c0\u817a\u7d20\u8f49\u57fa\u56e0\u6fb1\u7c89\u6a23\u8b8a\u6027\u75c5\u3002<\/p>\n

\u76ee\u524d\uff0c\u6b50\u6d32\u5df2\u7d93\u6279\u51c6\u4e86\u53e6\u4e00\u7a2e\u5f62\u5f0f\u7684\u904b\u7532\u72c0\u817a\u7d20\u86cb\u767d\u7a69\u5b9a\u5291\u7528\u65bc\u60a3\u67091\u671f\u75c7\u72c0\u6027\u591a\u767c\u6027\u795e\u7d93\u75c5\uff08ATTR-PN\uff09\u7684\u6210\u5e74\u60a3\u8005\u7684\u904b\u7532\u72c0\u817a\u7d20\u86cb\u767d\u6fb1\u7c89\u6a23\u8b8a\u6027\u75c5\uff0c\u4ee5\u5ef6\u9072\u5468\u570d\u795e\u7d93\u529f\u80fd\u969c\u7919\u3002<\/p>\n

\u6b50\u76df\u59d4\u54e1\u6703\u7684\u6700\u7d42\u6c7a\u5b9a\u901a\u5e38\u9700\u898160\u5929\u5de6\u53f3\uff0c\u4f46\u6700\u8fd1\u8da8\u5411\u65bc\u63a5\u8fd130\u5929\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

Eagle Pharmaceuticals (EGRX +2.5%) has settled all patent issues with Eli Lilly (LLY -0.3%) related to the latter’s chemo drug Alimta (pemetrexed for injection). The FDA grants 510(k) clearance to Boston Scientific’s (BSX +0.7%) EXALT Model D, a single-use duodenoscope (a hollow lighted tube for inspecting the small intestine) for use in endoscopic retrograde cholangiopancreatography procedures (aimed at diagnosing issues in the liver, gallbladder, bile ducts and pancreas).<\/p>\n","protected":false},"author":9,"featured_media":309840,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,564],"class_list":["post-309855","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/309855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=309855"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/309855\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/309840"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=309855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=309855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=309855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}